148 related articles for article (PubMed ID: 34684070)
1. Inherited/Genetically-Associated Pheochromocytoma/ Paraganglioma Syndromes and COVID-19.
Ilias I; Kaltsas G; Barkas K; Chrousos GP
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684070
[TBL] [Abstract][Full Text] [Related]
2. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.
Albini A; Di Guardo G; Noonan DM; Lombardo M
Intern Emerg Med; 2020 Aug; 15(5):759-766. PubMed ID: 32430651
[TBL] [Abstract][Full Text] [Related]
3. Hereditary paraganglioma-pheochromocytoma syndrome.
Sanchez Cifuentes A; Candel Arenas MF; Albarracín Marín-Blazquez A
Med Clin (Barc); 2018 Nov; 151(10):e57-e58. PubMed ID: 29656766
[No Abstract] [Full Text] [Related]
4. New advances in the genetics of pheochromocytoma and paraganglioma syndromes.
Gimenez-Roqueplo AP
Ann N Y Acad Sci; 2006 Aug; 1073():112-21. PubMed ID: 17102078
[TBL] [Abstract][Full Text] [Related]
5. Hereditary pheochromocytoma and paraganglioma.
Mazzaglia PJ
J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
[TBL] [Abstract][Full Text] [Related]
6. The pheochromocytoma and paraganglioma syndrome: founder effects and the PGL 1 syndrome.
Opocher G; Boaretto F; Pignataro V; Demattè S; Cecchini ME; Erlic Z; Schiavi F
Ann Endocrinol (Paris); 2009 Jun; 70(3):157-60. PubMed ID: 19286157
[No Abstract] [Full Text] [Related]
7. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.
Benn DE; Richardson AL; Marsh DJ; Robinson BG
Ann N Y Acad Sci; 2006 Aug; 1073():104-11. PubMed ID: 17102077
[TBL] [Abstract][Full Text] [Related]
8. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
Baysal BE; Maher ER
Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
[TBL] [Abstract][Full Text] [Related]
9. Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.
Björklund P; Pacak K; Crona J
J Intern Med; 2016 Dec; 280(6):559-573. PubMed ID: 27165774
[TBL] [Abstract][Full Text] [Related]
10. Genetic Screening in Pheochromocytoma/Paraganglioma.
Liu P; Zu X; Liu L
Pathol Oncol Res; 2017 Jan; 23(1):217. PubMed ID: 27699629
[No Abstract] [Full Text] [Related]
11. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
13. SDH-related pheochromocytoma and paraganglioma.
Kantorovich V; King KS; Pacak K
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):415-24. PubMed ID: 20833333
[TBL] [Abstract][Full Text] [Related]
14. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
[TBL] [Abstract][Full Text] [Related]
15. The genetic basis of pheochromocytoma and paraganglioma: implications for management.
Shuch B; Ricketts CJ; Metwalli AR; Pacak K; Linehan WM
Urology; 2014 Jun; 83(6):1225-32. PubMed ID: 24642075
[TBL] [Abstract][Full Text] [Related]
16. Genetics of pheochromocytomas and paragangliomas.
Opocher G; Schiavi F
Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):943-56. PubMed ID: 21115163
[TBL] [Abstract][Full Text] [Related]
17. Familial pheochromocytoma.
Erlic Z; Neumann HP
Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2.
Hallaj S; Ghorbani A; Mousavi-Aghdas SA; Mirza-Aghazadeh-Attari M; Sevbitov A; Hashemi V; Hallaj T; Jadidi-Niaragh F
Immunol Cell Biol; 2021 Feb; 99(2):192-205. PubMed ID: 32864784
[TBL] [Abstract][Full Text] [Related]
19. Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma.
Nakamura E; Kaelin WG
Endocr Pathol; 2006; 17(2):97-106. PubMed ID: 17159241
[TBL] [Abstract][Full Text] [Related]
20. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
